课题基金 / 基金详情

First-In-Human Feasibility Trial of Break Wave - The Office-Based Lithotripsy Solution

First-In-Human Feasibility Trial of Break Wave - The Office-Based Lithotripsy Solution
Break Wave 的首次人体可行性试验 - 基于办公室的碎石解决方案
批准号:
9919546
负责人:
Oren Levy
金额:
$99.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-01 至 2022-03-31

项目摘要

项目成果

Oren Levy的其他基金

相似基金

相关文献

中文摘要
翻译
意义:需要一种安全有效的办公室碎石治疗肾结石。
英文摘要
Significance: There is a need for a safe and effective office-based lithotripsy treatment for kidney stones. Kidney stones are common; they affect nearly 10% of the US population and the prevalence continues to grow in parallel with diseases such as high blood pressure, diabetes, and obesity. Kidney stones are also one of the most costly urologic diseases in America; the health care burden in the US exceeds $10 billion annually. A substantial portion of this cost is due to the approximately one million surgical interventions and 20-40% rate of unplanned post-surgical events. This includes extracorporeal shock wave lithotripsy (SWL), a common noninvasive surgical intervention, and ureteroscopy laser lithotripsy (URS), a common endoscopic procedure. Both have a 5% or greater risk of significant adverse events and, in the US, both procedures are conducted within a surgical suite with the patient anesthetized. Technology: SonoMotion is developing an office-based, non-invasive, and anesthesia free stone lithotripsy solution for kidney and ureteral stones to redefine the standard of care for millions of people. Break WaveTM (i.e. BWL) is a novel method of stone fragmentation that uses multi-cycle, low-amplitude pulses of ultrasound rather than shock waves to induce stone fracture. This approach has the potential to reduce the risk of injury and the rate of procedural complications, as well as significantly lower procedural time and cost. Furthermore, the low amplitude pulses will preclude the need for anesthesia, providing an office-based treatment method. This could also potentially provide an attractive alternative to active surveillance of an obstructing stone. Preliminary Data: In vitro studies have shown the Break Wave technology is capable of fragmenting most common human stones into fragment sizes that are consistently less than 1 mm. Clinical simulation conducted in a porcine model indicates the pressure levels required to break stones are below the pressure levels required to induce renal injury. Specific Aims: Aim 1 is a 30-patient, prospective, open-label, multi-center, single-arm First-In-Human feasibility clinical trial to assess the safety and effectiveness of Break Wave. Subjects presenting with upper urinary tract stones will be recruited as an alternative to SWL. Effectiveness is to be determined by stone passage, post-treatment low dose CT imaging, and the need for secondary procedures; safety is to be evaluated through the documented occurrences of adverse events, post-procedural imaging, unplanned physician/ED visits. Procedural tolerance and effectiveness will also be evaluated at multiple pressure levels and at reduced to no anesthesia. The trial will be conducted across 4 centers to derive a broad range of feedback across multiple well-established urologists. Throughout the trial, SonoMotion will identify device design and procedural adjustments to improve safety and effectiveness, and implement those changes in Aim 2. Aim 2 will also implement and test expanding the beam width to break larger stones and accommodate greater patient movement. The outcome of this grant will be a clinical-ready system to initiate a pivotal clinical trial for FDA regulatory approval.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Commercial readiness of Break Wave - The SonoMotion Office-Based Lithotripsy Solution
  • 批准号:
    10385222
  • 项目类别:
  • 资助金额:
    $40.0万
  • 财政年份:
    2021
  • 负责人:
    Oren Levy
  • 依托单位:
Burst Wave Lithotripsy for the Treatment of Ureteral Calculi
  • 批准号:
    9361764
  • 项目类别:
  • 资助金额:
    $77.01万
  • 财政年份:
    2017
  • 负责人:
    Oren Levy
  • 依托单位:
Non-invasive Promotion of Clearance of Kidney Stones and Fragments
  • 批准号:
    9144610
  • 项目类别:
  • 资助金额:
    $73.69万
  • 财政年份:
    2015
  • 负责人:
    Oren Levy
  • 依托单位:
海外基金